IsoPlexis Reports Second Quarter 2022 Financial Results

Go back to IsoPlexis Reports Second Quarter 2022 Financial Results

Morgan Stanley Downgrades IsoPlexis Corp (ISO) to Equalweight

August 11, 2022 8:21 AM EDT

Morgan Stanley analyst Tejas Savant downgraded IsoPlexis Corp (NASDAQ: ISO) from Overweight to Equalweight with a price target of $5.00.

The analyst comments "The miss/cut reflects EU macro headwinds, Chinese COVID impact & a short-term reorg-driven disruption; while streamlining efforts support improving... More

IsoPlexis Corporation (ISO) Misses Q2 EPS by 13c

August 10, 2022 7:16 AM EDT

IsoPlexis Corporation (NASDAQ: ISO) reported Q2 EPS of ($0.65), $0.13 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $4 million versus the consensus estimate of $5.55 million.

For earnings history and earnings-related data on IsoPlexis Corporation (ISO) click here.

... More